Study of hypochondroplasia in children
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study is for children with hypochondroplasia, a condition that causes short stature. It will look at how the condition changes over time and aims to better understand it, with the goal of finding new treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 2.5 and 16 years old.
- You must have a confirmed diagnosis of hypochondroplasia from a genetic test.
- You must be able to walk and stand without help.
- You and your parent or guardian must be willing to follow the study schedule and procedures.
- You cannot have achondroplasia or any other cause of short stature besides hypochondroplasia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication called infigratinib in children with hypochondroplasia, a form of short stature. It aims to see if the drug can help improve growth and is for children who are still growing.
This study is for children with hypochondroplasia who already completed the ACCEL 2/3 trial. It tests the long-term safety and effects of the study drug infigratinib, and gives continued access to the treatment.
This study observes children with hypochondroplasia to learn more about the condition. It does not involve any treatment—just monitoring and data collection to help future research.
This study tests a daily injection called vosoritide to see if it helps children with hypochondroplasia grow taller. It is for babies and toddlers up to 35 months old who are shorter than average for their age.
this study is a long-term extension of the main study for the drug which from Bio? bi? whatever? in the name? by?...????
This study tracks how people with achondroplasia or hypochondroplasia move their arms and legs over time. It uses a small wearable device to measure movement and may help doctors understand daily mobility better.
Hear when a new Hypochondroplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.